Skip to content

Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial.

Preservation of Endopelvic Fascia During Radical Prostatectomy: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02526602
Enrollment
158
Registered
2015-08-18
Start date
2015-08-31
Completion date
2019-09-30
Last updated
2019-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction, Prostatic Neoplasms, Urinary Incontinence

Brief summary

Urinary incontinence and impotence are typical disturbances after radical prostatectomy. Although, several surgical methods are developed to decrease these disturbances, 8% and 50% of the patients suffer from permanent urinary incontinence and impotence, respectively. Previously two studies have shown that endopelvic fascia preservation may decrease postoperative incontinence and impotence rates. Unfortunately these studies are retrospective decreasing their reliability. The present study is prospective and randomized clinical trial. The investigators are going to randomize 180 patient to preservation and opening the endopelvic fascia groups. Functional and oncological results are followed up to 1 year after surgery.

Detailed description

180 patients going to radical prostatectomy as treatment of prostate cancer will be randomized 1:1 to two study arms: In the other arm endopelvic fascia are preserved during the operation, in the other arm the fascia are opened. After the operation urinary continence and erection function are compared between the study arms. Additionally the investigators will study oncological outcomes.

Interventions

PROCEDUREPreservation (endopelvic fascia)

Robotic assisted radical prostatectomy with preserving of endopelvic fascia

PROCEDUREOpening (endopelvic fascia)

Robotic assisted radical prostatectomy with opening of endopelvic fascia

Sponsors

Tampere University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Localized prostate cancer * Planned nerve-sparing robotic radical prostatectomy * Gleason score 7 or less

Exclusion criteria

* Previous prostate surgery (TURP, TUIP, laser...) * Planned lymphadenectomy * T3 cancer

Design outcomes

Primary

MeasureTime frameDescription
Urinary incontinence1 yearEPIC-26 questionnaire preoperatively and 3 and 12 months after surgery
Erectile function1 yearEPIC-26 questionnaire preoperatively and 3 and 12 months after surgery

Secondary

MeasureTime frameDescription
Complications1 yearClavien-Dindo classification
Oncologic results: positive surgical margin rate1 yearPositive surgical margin rate as reported in pathological analysis of the removed prostate

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026